NCT06391580View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit

NANot yet recruitingINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2025

Conditions
Jawline Contour Deficit
Interventions
DEVICE

Poly-L-lactin Acid (PLLA) Based Facial Injectable

Poly-L-lactin Acid (PLLA) Based Facial Injectable

Trial Locations (1)

Unknown

Beijing Hospital, Beijing

All Listed Sponsors
lead

Sinclair Pharmaceuticals Limited

INDUSTRY

NCT06391580 - A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit | Biotech Hunter | Biotech Hunter